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Objective: Inflammatory abdominal aortic aneurysms (IAAAs) have been traditionally managed with open repair.
Endovascular aneurysm repair (EVAR) was approved September of 1999. Some authors have suggested that EVAR is not
an acceptable option for management of an IAAA. However, several recent reports have suggested EVAR is a reasonable
management option in these patients. The purpose of our study was to review our experience with the contemporary
management of IAAA involving both open and endovascular approaches.
Methods: A retrospective review of all patients undergoing repair of IAAAs from 1999 to 2011 was conducted at three
geographically separate institutions. Basic demographics, diagnostic workup, treatment, and outcomes were reviewed.
Results: Between 1999 and 2011, 69 patients underwent surgical repair of IAAAs, 59 by open repair and 10 by EVAR.
Eighty-three percent of patients were men with a mean age of 67. Aneurysm size was similar in both groups (6.3 cm open
repair vs 5.9 cmEVAR). Follow-up for the open groupwas amean of 42.6months and 33.6months for the EVAR group.
Periaortic fibrosis decreased from a mean of 5.4 mm to 2.7 mm after EVAR. Hydronephrosis was present preoperatively
in one patient and did not change after EVAR. Aneurysm size decreased in seven patients (70%) who underwent EVAR.
Two patients had no change with one lost to follow-up. Mean aneurysm size decrease after EVAR was 1.12 cm (17.8%).
There were no aneurysm-related deaths or major morbidities in the EVAR group. Twenty-two patients (37%) in the open
surgical group suffered major complications, including myocardial infarction, renal failure, lower extremity amputation,
sepsis, and prolonged ventilation.
Conclusions: Endovascular repair for IAAA results in successful management with improvement of periaortic inflamma-
tion. EVAR should be considered as first-line therapy in which anatomic parameters are favorable. ( J Vasc Surg 2012;56:
951-6.)
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wAs early as 1935, the entity of inflammatory aortic
aneurysms was apparent. James1 reported the findings in a
patient with uremia secondary to renal involvement from a
retroperitoneal inflammatory process. The patient was also
noted to have a large abdominal aortic aneurysm. In 1955,
Garrett and Schumacker2 reported the case of a 13-cm
abdominal aortic aneurysm presenting with fibrosis and
retroperitoneal inflammation. The patient also had ureteral
obstruction. In 1972, Walker et al3 reported a series of 19
patients who had abdominal aortic aneurysms and retroper-
itoneal fibrosis. They were the first to use the term “inflam-
matory aneurysms.” Approximately 3% to 10% of abdomi-
nal aortic aneurysms are characterized by increased
inflammation surrounding the aneurysm.4 This is classically
described as a white glistening fibrotic surface with a thick-
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tructures, such as the ureter and the duodenum, are fre-
uently present.
In inflammatory abdominal aortic aneurysms (IAAAs),
istologically, the elastic and muscular fibers of the aortic
edia have been replaced by fibrotic tissue. Plasma cells
nd inflammatory cells such as lymphocytes are also pres-
nt.5 Patients clinically present with symptoms of abdomi-
al and/or back pain; fatigue and weight loss are also
ommon. Frequently noted is an elevated erythrocyte sed-
mentation rate. The key to diagnosis is the degree of
etroperitoneal fibroses.
The fibrotic changes represent an increased risk of
orbidity during open surgery. This has been reported
umerous times in the literature with suggestions of higher
orbidity, higher mortality, longer operating time, and
ncreased need for transfusions.6 It has been theorized that
ndovascular aneurysm repair (EVAR) could offer an ad-
antage in the treatment of IAAAs. There are numerous
eports that conflict on the advantages and the disadvan-
ages of treating IAAAs with EVAR.7-10 We undertook this
nalysis in an effort to evaluate the results at one distinct
nstitution in three separate geographic locations with the
ndovascular treatment of IAAAs.
ETHODS
A retrospective review was performed on all patients
ith the diagnosis of IAAA undergoing repair from January
, 1999, through July 31, 2011, in theMayoClinic System.
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ter, Minn, Phoenix, Ariz, and Jacksonville, Fla. Institu-
tional review board approval for a retrospective review was
attained through our enterprise. The diagnosis of IAAA
was made by the operating surgeon at the time of interven-
tion in those patients undergoing open repair and was
dependent upon the clinical judgment of the vascular sur-
geon. In patients undergoing EVAR, the diagnosis of
IAAA was made by radiologic interpretation of computed
tomography (CT). Medical records were abstracted to in-
clude basic demographic information, preoperative symp-
toms, aneurysm size measurements, intraoperative details,
perioperative complications, and long-term imaging. Ex-
cluded from review were those patients who had inflamma-
tion noted on radiographic imaging but were not deemed
by the surgeon to have a true inflammatory aneurysm at the
time of surgery. Also excluded were those patients with
infectious etiologies. Statistical analysis was performed us-
ing unpaired t-tests and 2 analysis.
RESULTS
During the 12-year study period, 69 patients under-
went intervention for repair of IAAAs andwere included for
review (Table). During the same time period, approxi-
mately 3500 non-IAAAs were repaired. The mean age of
patients undergoing interventions for IAAAs was 67.1 years
(range, 23-83 years), including 53 men (77%) and 16
women (23%). The youngest patient in the series suffered
from Takayasu arteritis. The majority of patients experi-
enced symptoms of pain (36 of 69; 52%). Four patients
(5.6%) presented with ruptured IAAAs. Ureteral involve-
ment in the inflammatory process by CT imaging was seen
in 23 patients (32.3%) and 21 of the 23 (91.3%) underwent
preoperative ureteral stent placement. Although the in-
flammation seemed to involve the ureters in 23 patients,
hydronephrosis was seen in only 13 patients (18.8%) pre-
operatively. Mean preoperative aneurysm size in the overall
group was 6.2 cm in maximum diameter (range, 3.4-11.3
cm) and did not include the rind. Follow-up ranged from 1
to 144 months with a mean of 41.1 months (median, 27.7
months). Eighteen patients were lost to follow-up (25.7%).
There was one postoperative death (1.4%) in a patient
Table. IAAA preoperative age and aneurysm size
Age, years EVAR
No. of patients 10
Mean (SD) 72.2 (8.02) 6
SEM 2.54
Median 71.5
Range (62.0-82.0) (
Preoperative size
No. of patients 10
Mean (SD) 5.9 (1.24)
SEM 0.39
Median 6.0
Range (4.0-8.3) (
EVAR, Endovascular aneurysm repair; IAAA, inflammatory abdominal aorundergoing open repair for a ruptured suprarenal IAAA. rThe decision to pursue open or endovascular interven-
ion was surgeon-dependent and included anatomic con-
iderations. In all cases of open surgical intervention, in-
ammatory aneurysm was suspected preoperatively then
onfirmed or excluded in the operating room. All surgeons
nvolved in the treatment of these patients were experi-
nced in EVAR at the time of intervention.
Open repair. Fifty-nine of the 69 patients (85.5%)
ith IAAA underwent conventional open aneurysm repair
uring the study period. Mean age for the open group was
6.2 years (range, 23-83 years), including 45 men (77%)
nd 14 women (23%). Most patients (31 of 59; 52.5%) had
ain before intervention. The youngest patient (age 23)
uffered from Takayasu arteritis. Three patients (5.0%)
resented with a ruptured aneurysm. Ureteral involvement
ith inflammation was present in 21 patients (34.4%) and
reoperative ureteral stent placement was performed in 19
f these patients. Most of these stents were placed preop-
ratively to assist with identification of the ureters due to
he surgeon’s preference. Hydronephrosis was present pre-
peratively in 12 patients (20.3%). Four patients (6.7%)
ere treated with perioperative steroids. This was done in
ll patients for treatment of comorbid conditions and not
or resolution of the inflammatory process. Suprarenal aor-
ic cross-clamping was required for repair in 36 of these
atients (61%) to attain adequate control of the aorta.
Preoperative mean aneurysm size was 6.3 cm in maxi-
al diameter (range, 3.4-11.3 cm). The operative ap-
roach was most commonly through a midline abdominal
ncision, which was performed in 52 patients (88%). Addi-
ionally, a retroperitoneal approach was utilized in six pa-
ients (10%), and bilateral subcostal incision was performed
n one patient (1.6%). Twenty-two major postoperative
omplications occurred in these 59 patients (37.9%) under-
oing open repair. These complications included signifi-
ant renal insufficiency in five patients (8.3%) needing
ostoperative dialysis. Two of these patients required long-
erm postoperative dialysis. Ischemic colitis was present
n two patients (3.3%), but no patient required colonic
esection. Postoperative ureteral obstruction requiring in-
ervention was present in three patients (4.9%). Other
evere complications included lower extremity ischemia
pen Total
69
10.43) 67.1 (10.29)
.36 1.24 (P  .09)
.0 68.0
83.0) (23.0-83.0)
66
1.57) 6.2 (1.52)
.21 0.18 (P  .51)
.0 6.0
1.3) (3.4-11.3)
urysm.O
59
6.2 (
1
68
23.0-
56
6.3 (
0
6
3.4-1equiring bilateral above-knee amputations in one pa-
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Volume 56, Number 4 Stone et al 953tient with significant mural thrombus, basilar artery an-
eurysm rupture with hemorrhage, and subsequent full
recovery in one patient, cholecystitis in one patient, and
sepsis from a urinary tract infection in one patient. One
patient underwent conventional open repair unevent-
fully but 5 years postrepair developed a distal anasto-
motic suture line rupture, which was successfully re-
paired with an endovascular graft. There was one death
(1.6%) in the 30-day postoperative period in a patient
presenting with a ruptured suprarenal IAAA. There were
no aneurysm-related deaths identified during follow-up.
Mean follow-up was 42.6 months (median, 29.0
months) with a range of 1 to 144 months. Seventeen
patients were lost during the follow-up period (28.3%).
Forty-two patients (71.1%) had postoperative imaging. Of
those 42 patients, all had resolution of the aneurysm sac.
Hydronephrosis was found to resolve in seven of 12 pa-
tients (58.3%). In four of 12 patients (33%), the hydrone-
phrosis remained stable, but two of those patients developed
renal atrophy likely related to persistent hydronephrosis. In
one patient (8.3%), the hydronephrosis worsened, and ureter-
olysis was required.
Endovascular repair. There were 10 patients (14%)
that underwent EVAR for management of their IAAAs
during the study period. The mean age was 72.2 years with
an age range of 62 to 82 years. The EVAR group consisted
of eight men (80%) and two women (20%). Preoperatively,
eight patients (80%) experienced abdominal pain and one
patient (10%) presented with a ruptured aneurysm. Two
patients (20%) had ureteral involvement in the inflamma-
tory process and one of those required preprocedural stent-
ing. Hydronephrosis was present in one patient (10%).
Preoperative mean aneurysm size was 5.9 cm in maximal
diameter (range, 4.0-8.3 cm). Repair was accomplished in
all 10 patients and included four patients with an AneuRx
device (Medtronic, Santa Rosa, Calif), four patients with a
Zenith device (Cook Inc, Bloomington, Ind), one patient
with an Excluder device (W. L. Gore and Associates, Flag-
staff, Ariz), and one patient with an Ancure device (Guidant,
Indianapolis, Ind).
Postoperative aneurysm size decreased in seven patients
(70%), with two patients (20%) showing no change in
aneurysm size and one patient lost during the follow-up
period. Mean follow-up was 33.6 months (median, 26.9
months) with a range of 2 to 109 months. Postoperative
mean aneurysm size was 4.73 cm in maximal diameter. The
mean change in size was a decrease of 1.12 cm in maximum
diameter. Of all patients with postoperative imaging, there
was a mean change in aneurysm size of 17.8% (range,
57.6%-0%). The only patient with preoperative hydrone-
phrosis developed renal atrophy postoperatively due to
worsening of the hydronephrosis. One other patient that
did not have hydronephrosis preoperatively developed it in
the postoperative period. The inflammatory rind preoper-
atively measured 5.4 mm mean in patients with IAAAs
undergoing EVAR. Postoperatively, the mean size of in-
flammatory rind was 2.7 mm. One patient had an increase
in the size of the inflammatory rind but had no change in Ahe size of the aneurysm sac. All other patients had a
ecrease in the size of the inflammatory rind. Mean change
n the size of the inflammatory rind was 50.8% (range,
2.1%-0%). No patient was given steroids in the EVAR
roup. Postoperative abdominal pain was resolved in six of
even patients (85.7%) after EVAR repair. One of the
ymptomatic patients was lost to follow-up.
Two patients (20%) developed atrial fibrillation post-
peratively, but there were no other significant compli-
ations reported. No patient required subsequent inter-
ention for repair of the aneurysm and no endoleaks were
dentified in follow-up. There was no perioperative mor-
ality and no patient died of aneurysm-related causes
uring the follow-up period.
Although statistically difficult to analyze, there was no
tatistical significant difference noted between the open
roup and the EVAR group comparing age (P  .09),
neurysm size, and length of follow-up. Small numbers in
he EVAR group preclude meaningful comparison, but the
everity of complications in the open group was much
reater than in the EVAR group.
ISCUSSION
The outcomes of open surgery for management of
nflammatory aneurysms are fraught with an increased com-
lication rate compared to noninflammatory aneurysms. In
large classic series, it was demonstrated that operative
ortality increased threefold when comparing inflamma-
ory to noninflammatory aneurysms.6 In addition, there is a
ignificant increase in major morbidity between open sur-
ery for IAAAs compared to non-IAAAs.11 It has been
ointed out that in the early years of vascular surgery,
xtensive adhesiolysis was routinely performed.12 This
ractice led to major complications, including enteroto-
ies and duodenal injury. Furthermore, there was a signif-
cant rate of ureter injuries due to this extensive adhesioly-
is. In order to decrease the perioperative complications, it
as suggested in the late 1970s that avoidance of extensive
dhesiolysis was prudent and it was suggested to utilize
uprarenal aortic clamping with endoaneurysmorrhaphy.13
In light of this significant increased morbidity and
ortality from open repair of inflammatory aneurysms, the
ption of EVAR seems intuitive. However, the benefit
rom endovascular intervention is still unproven. Does the
ndovascular approach reduce not only the risk of aneurys-
al rupture, but does it also reduce the long-term risk of
eriaortic fibrosis (PAF) and subsequent renal complica-
ions? Not only are the ureters potentially involved in the
nflammatory process, but the duodenum and kidneys may
e at risk due to the severe PAF. Certain groups, such as
he one from Liverpool,14 would suggest that EVAR is
ot suitable for IAAA repair due to increased morbidity
nd risk of iatrogenic injury to retroperitoneal structures.
ther publications, such as the meta-analysis from the
UROSTAR and other meta-analyses, suggest mixed
esults.8-10,15
The technical success of EVAR in our study was 100%.
ll of the aneurysms undergoing attempt at endovascular
s
o
w
w
m
m
t
t
t
s
d
l
s
d
g
d
E
E
o
p
a
b
a
P
4
t
s
w
i
m
o
P
r
o
r
i
m
t
N
N
w
i
h
9
g
1
v
n
o
b
m
e
i
E
JOURNAL OF VASCULAR SURGERY
October 2012954 Stone et alrepair were successfully treated. Aneurysm size was signifi-
cantly reduced in this group of patients. The amount of
PAF was significantly reduced in six of seven patients who
had follow-up CT scans. One of those seven patients dem-
onstrated stable inflammatory thickness in follow-up. An-
eurysm sac shrinkage was present in seven of nine patients.
The remaining two patients had no change in the size of the
aneurysm sac. There were no endoleaks identified in any
patient undergoing endovascular repair during periproce-
dural imaging or during long-term follow-up.
Our study has several limitations owing to the inclusion
of only our institution and the retrospective nature of the
study. One difficulty in a retrospective study like this is the
lack of clear criteria for inflammatory aneurysms. The diag-
nosis was left to the surgeon in the setting of open surgical
intervention and the radiologist in cases of endovascular
intervention. Where some amount of periaortic inflamma-
tion was present but the aneurysm lacked the classic glis-
tening white appearance of an inflammatory aneurysm, the
surgeon most often diagnosed a noninflammatory aneu-
rysm. This conservative approach may limit the power of
the study but stays more true to the study purpose. Longer
follow-up is always better, but our results give no indication
that further follow-up would alter the results.
In a series involving nine patients from Modena, Italy,
the long-term results of endovascular repair are dis-
cussed.16 They reported survival rates with follow-up as
long as 60 months. Technical success was achieved in a
significant number with low mortality. Aneurysm sac
shrinkage occurred in 89% of their patients. There was no
aneurysm rupture or aneurysm-related deaths; however, in
those patients with a hydroureter or hydronephrosis, the
results were significantly reduced compared to open repair.
Reduction in the inflammatory process of 55% was seen by
measuring the PAF in this group of patients. This is not
dissimilar to our results.
One of the most extensive series of EVAR for IAAAs to
date would be the report from the EUROSTAR database.8
This study compares the results of IAAAs vs non-IAAAs
both managed with EVAR. This series includes 52 patients
with IAAAs, which represents 1.4% of the EUROSTAR
data. All patients had the diagnosis of inflammatory aneu-
rysm made by CT imaging. The mean age of patients with
inflammatory aneurysms was approximately 6 years younger
than those with noninflammatory aneurysms. Other signifi-
cant differences found in this series, and pointed out by other
large series of inflammatory aneurysms, are that the risk of
smoking was significantly greater in patients with inflamma-
tory aneurysms and the instance of hypertension was signifi-
cantly less. Also, cardiac and pulmonary disease is less com-
mon. Perhaps the younger age of patients with inflammatory
aneurysms relates to the less cardiac and pulmonary pre-
existing conditions. Operating time for inflammatory aneu-
rysms when placing endografts in comparison to nonin-
flammatory aneurysms was not significantly different.
There was a significant increase in the rate of limb stenosis
or occlusion in patients with inflammatory aneurysms. This
may be related to the severe inflammatory fibrotic reaction surrounding the aneurysm. This finding was not found in
ur present series; however, only one endovascular device
as placed that did not have external support in our group,
hich may explain our results. Overall, morbidity and
ortality were not significantly different between inflam-
atory and noninflammatory aneurysms. Minor complica-
ions, such as access site infections, were likewise not statis-
ically different.
The EUROSTAR data also provide results for long-
erm outcomes.8 It is interesting to note that there was no
ignificant difference in the rate of endoleaks. There was no
ifference in device migration, kinking, or thrombosis
ong-term. There was also no difference in aneurysm
hrinkage between the two groups. What was significantly
ifferent was the worsening of renal function in the IAAA
roup. If patients were followed long term, renal function
eteriorated in 27% of all patients with IAAAs. The effect of
VAR on the amount of inflammatory fibrosis is less clear.
VAR demonstrated a significant reduction in the amount
f inflammation in approximately half of the patients.
The results published by Puchner et al10 from Vienna
arallel the results of the EUROSTAR data. This meta-
nalysis of the treatment of inflammatory aortic aneurysms
y EVAR had a mean follow-up of 18 months. The results
re quite similar to both ours and the EUROSTAR data.
AF was reduced by approximately 51% in this group; in
2%, there was no significant change in PAF; and in 7%,
here was an increase in the PAF. Only 45.8% showed
ignificant improvement in hydroureter or hydronephrosis,
hereas 54.2% showed no significant change. In this series,
n comparison to our reported results, there was a large
ale predominance, similar to the EUROSTAR, with 98%
f the patients being men. In another large meta-analysis,
aravastu et al15 presented a review of open vs endovascular
epair for inflammatory aortic aneurysms. They again dem-
nstrated a significantly higher mortality rate with open
epair (6.2% vs 2.4%). They suggest that there is no signif-
cant difference in open vs EVAR on the degree of inflam-
atory process. Patients demonstrating significant reduc-
ion in fibrosis were 73% open vs 65% with use of EVAR (P
S), whereas those that are unchanged is 26% vs 30% (P
S). In the open group, hydronephrosis and hydroureter
as improved in 69% of the patients, whereas only 38%
mproved in the EVAR group (P  .01). In addition, the
ydronephrosis or hydroureter progressively worsened in
% in the open group vs 21% of the patients in the EVAR
roup. It must be pointed out, however, that the all-cause
-year mortality was significantly greater in the open group
s the EVAR group (P  .01).
EVAR in itself increases the rate of inflammation. It is
ot as immediate a response as an open repair; however,
ver time, it may be significant.17 It has been hypothesized
y numerous authors that this increase in inflammation
ay be due to a reaction to the Dacron graft in the
ndograft; however, similar results have been demonstrated
n grafts using polytetrafluoroethylene. The possibility that
VAR generates its own inflammatory reaction adds to the
kepticism that endovascular repair will permit the resolu-
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Volume 56, Number 4 Stone et al 955tion of inflammation after repair in IAAAs. This skepticism
is unfounded based on our results in which inflammation
improved in all cases of EVAR.
Numerous reports demonstrate, similar to our present
series, that EVAR treatment for inflammatory aneurysms
successfully reduces the size of the aortic aneurysm in a
majority of patients. It also reduces the amount of PAF but
not to the extent that open aneurysm repair does. Endo-
vascular repair outcomes are achieved with a lower morbid-
ity and 1-year mortality. The Achilles’ heel of EVAR repair
for IAAAs revolves around renal and ureter involvement.
Hydroureter and hydronephrosis demonstrate inferior out-
comes with EVAR compared to open repair. This may be
related to the fact that the PAF resolves at a slower and less
robust rate. However, this is purely a hypothesis. Based on
our results and results in the literature, one would suggest
that EVAR is appropriate treatment for IAAAs where there
is no renal or ureter involvement in the inflammation. It
may also be successful treatment for a percentage of pa-
tients in which they are poor open surgical risks.
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Dr Thomas Naslund, MD (Nashville, Tenn). The authors
have succeeded in advancing our knowledge of the role EVAR
holds in treating this uncommon but complex vascular disease.
Results from open as well as endovascular repair in this series are
admirable and represent a standard all of us can look up to in our
own efforts to manage these problematic aneurysms.
Your series is large for a study involving IAAAs, only 10
patients were treated with EVAR, whereas 59 were treated by open
repair. Your proportion of patients managed with EVAR is similar
to other practices favoring open repair. One reason that IAAAs are
infrequently managed with EVAR is the opinion that reduction in
inflammatory change is suboptimal. This report demonstrates that
inflammatory findings on CT scan improve after EVAR and, based
on correlations with other studies, likely similar to the reduction ofbrosis and ureteral entrapment is less complete with EVAR than
ith open repair. This finding should be considered when indica-
ion for surgery is ureteral entrapment.
I pose three questions to the authors. (1) What happens to the
atients’ pain from IAAA after EVAR? (2) Should steroids be
dded to EVAR to improve resolution of inflammation? (3) Have
ou identified any technical tips in performing EVAR in IAAA?
Dr Grant T. Fankhauser. Thank you, Dr Naslund, I appre-
iate your kind comments and I appreciate your questions. First of
ll, in regard to the pain scenario, it is very difficult in the retro-
pective review to have truly analyzed the pain and whether the
ain was resolved after the procedure. That really was not part of
ur review. I will say though that the majority of the patients who
ad smaller aneurysms underwent repair of these aneurysms be-
ause they did have symptoms, most commonly, pain. So, I do not
ave a direct answer to what the relation of that is. When you look
t the literature, there is very little information that will relate to
a
I
p
s
s
k
m
s
t
JOURNAL OF VASCULAR SURGERY
October 2012956 Stone et alpain and resolution of pain after the procedure. In the question
regarding the addition of steroids, in the United Kingdom meta-
analysis, there is no question that addition of steroids in those small
select patients who had hydronephrosis was beneficial. It did add to
the resolution of the hydronephrosis. In our small series, with only
a few people who actually had steroid therapy, it is difficult for me
to make any meaningful statements about the effects of steroid
therapy, but there is literature that would suggest that adding
steroids in those patients who had recalcitrant hydronephrosis is aneurysm, because of the issue with limb kinkage and limb stenosis,
think you need to be very careful when you are doing your
ostimaging to be sure that there is not a kink or a significant
tenosis. You may find yourself using some sort of self-expanding
tent or another stent on the inside to try to prevent that or try to
eep that open. Because of the fibrotic change on the outside, it
ay cause more of a stenosis and, because you do not know for
ure whether that fibrosis is going to resolve, then I would suggest
hat you make sure that they are widely patent when you are done.reasonable option. Tips regarding endovascular repair when you
are preparing an inflammatory aneurysm vs an atherosclerotic
Other than that, you repair them pretty much in the same manner
as you would an atherosclerotic aneurysm.
